Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4695 - Impact of hyperbaric oxygenation on the expression of PKD1 protein forms in T98G glioblastoma cell line treated with selected pentabromobenzylisothiourea (ZKK-3)

Date

10 Sep 2017

Session

Poster display session

Topics

Cancer Biology;  Central Nervous System Malignancies

Presenters

Katarzyna Stepien

Citation

Annals of Oncology (2017) 28 (suppl_5): v109-v121. 10.1093/annonc/mdx366

Authors

K. Stepien1, R.P. Ostrowski2, E.B. Pucko2, E. Grzywaczewska2, E. Matyja2

Author affiliations

  • 1 Department Of Experimental And Clinical Neuropathology, Mossakowski Medical Research Centre Polish Academy of Sciences, 02-106 - Warsaw/PL
  • 2 Department Of Experimental And Clinical Neuropathology, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw/PL
More

Resources

Abstract 4695

Background

Glioblastoma (GBM) is the most malignant brain tumour with poor prognosis and limited therapy effectiveness. Tumour hypoxia is considered as a main reason of GBM’s resistance to medical treatment. It seems that improvement of therapeutic response can be achieved by the combination of chemotherapeutics application with refinement of oxygenation status of tumour tissue. One of the novel anti-tumour compounds is isothiourea derivative ZKK-3, which inhibits the activity of protein kinase D1 (PKD1). PKD1 promotes tumour growth and mediates detoxification of mitochondrial reactive oxygen species (ROS). The aim of this study was to examine the impact of hyperbaric oxygenation (HBO) on the expression of PKD1 protein as well as its phosphorylated forms - pPKD1 (Ser 916) and pPKD1 (Ser 744/748) in glioma cells treated with ZKK-3 in vitro.

Methods

Human glioblastoma T98G cell line was cultured in medium supplemented with ZKK-3 and exposed to the various oxygen conditions: normoxia, hypoxia, HBO, double hypoxia, hypoxia/HBO. After 24 hours of incubation cell lysis was made. The level of tested proteins in obtained lysates was examined using Western Blot technique.

Results

Increasing concentration of ZKK-3 caused diminution of PKD1, pPKD1 (Ser 916) and pPKD1 (Ser 744/748) levels in all tested oxygen conditions. Comparison of hypoxia and HBO conditions showed that hyperbaric oxygen administration resulted in enhancement of expressions of all PKD1 forms. Moreover, in groups preincubated in hypoxia conditions the levels of tested proteins were also markedly elevated after hyperbaric oxygenation (hypoxia/HBO) in comparison to the double hypoxia groups.

Conclusions

Increase of PKD1 protein expression as well as its phosphorylated forms evidenced that HBO application resulted in enhancement of oxidative stress in T98G cell line in vitro. This combined with ZKK-3 ability to inhibit activities of those kinases gives ground to consider ZKK-3/HBO therapy as a promising therapeutic strategy for patients with malignant gliomas. Acknowledgement: The research was supported by KNOW-MMRC project and Foundation for the Development of Diagnostic and Therapy.

Clinical trial identification

Legal entity responsible for the study

Mossakowski Medical Research Centre Polish Academy of Sciences

Funding

The research was supported by KNOW-MMRC project and Foundation for the Development of Diagnostic and Therapy.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.